Skip to content

This content is in French.

Acute respiratory failure: toward improved survival in immunocompromised patients?

5 mai 2026

Acute respiratory failure: toward improved survival in immunocompromised patients?

By Elodie Vaz | Published on May 5, 2026 | 4 min readAcute respiratory failure (ARF) is currently the leading cause of ICU admission among immunocompromised patients. Whether they have hematologic or solid malignancies, have undergone transplantation, or are receiving immunosuppressive therapy, this rapidly growing population remains particularly vulnerable. Despite advances in oncology, transplan

By Elodie Vaz | Published on May 5, 2026 | 4 min read


Acute respiratory failure (ARF) is currently the leading cause of ICU admission among immunocompromised patients. Whether they have hematologic or solid malignancies, have undergone transplantation, or are receiving immunosuppressive therapy, this rapidly growing population remains particularly vulnerable. Despite advances in oncology, transplantation, and critical care, ARF is still associated with high mortality, especially when invasive mechanical ventilation is required.

However, an international study coordinated by Professor Elie Azoulay (AP-HP Medical ICU), published on March 16, 2026, in The Lancet Respiratory Medicine, offers a note of hope: survival among these patients appears to be improving, particularly when ICU admission occurs early.

Sign in to read the rest

Reserved for healthcare professionals, free registration.

Scientific reference

View the source